18 related articles for article (PubMed ID: 36812708)
1. ABHD5 protects cardiac function in alcoholic cardiomyopathy via HDAC4-NT to inhibit CAMKII/MEF2 axis.
Lv X; Tian X; Dong B; Wang H; Su X; Liu B
J Appl Physiol (1985); 2023 Dec; ():. PubMed ID: 38095017
[TBL] [Abstract][Full Text] [Related]
2. Herpud1 suppress angiotensin II induced hypertrophy in cardiomyocytes.
Mikawa M; Sakai C; Yamamoto T; Nakamura Y; Tanaka S; Tominaga N; Inamitsu M; Oda T; Kobayashi S; Yano M
Biochem Biophys Rep; 2022 Jul; 30():101248. PubMed ID: 35313646
[TBL] [Abstract][Full Text] [Related]
3. CD38 promotes angiotensin II-induced cardiac hypertrophy.
Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
[TBL] [Abstract][Full Text] [Related]
4. Nuclear translocation of calmodulin in pathological cardiac hypertrophy originates from ryanodine receptor bound calmodulin.
Oda T; Yamamoto T; Kato T; Uchinoumi H; Fukui G; Hamada Y; Nanno T; Ishiguchi H; Nakamura Y; Okamoto Y; Kono M; Okuda S; Kobayashi S; Bers DM; Yano M
J Mol Cell Cardiol; 2018 Dec; 125():87-97. PubMed ID: 30359562
[TBL] [Abstract][Full Text] [Related]
5. FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca
Xiao YF; Zeng ZX; Guan XH; Wang LF; Wang CJ; Shi H; Shou W; Deng KY; Xin HB
J Cell Mol Med; 2018 Jul; 22(7):3638-3651. PubMed ID: 29682889
[TBL] [Abstract][Full Text] [Related]
6. Intracellular translocation of calmodulin and Ca2+/calmodulin-dependent protein kinase II during the development of hypertrophy in neonatal cardiomyocytes.
Gangopadhyay JP; Ikemoto N
Biochem Biophys Res Commun; 2010 May; 396(2):515-21. PubMed ID: 20433809
[TBL] [Abstract][Full Text] [Related]
7. Herpud1 modulates hypertrophic signals independently of calmodulin nuclear translocation in rat myocardium-derived H9C2 cells.
Fujioka R; Yamamoto T; Maruta A; Nakamura Y; Tominaga N; Inamitsu M; Oda T; Kobayashi S; Yano M
Biochem Biophys Res Commun; 2023 Apr; 652():61-67. PubMed ID: 36812708
[TBL] [Abstract][Full Text] [Related]
8. How does NFAT3 regulate the occurrence of cardiac hypertrophy?
Hui W; Wenhua S; Shuojie Z; Lulin W; Panpan Z; Tongtong Z; Xiaoli X; Juhua D
Int J Cardiol Heart Vasc; 2023 Oct; 48():101271. PubMed ID: 37753338
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
